| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
154,258 |
144,049 |
$15.44M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
57,695 |
54,591 |
$4.27M |
| 88185 |
|
6,532 |
6,481 |
$2.82M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
2,728 |
2,720 |
$2.56M |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
8,156 |
8,013 |
$2.34M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
34,478 |
23,740 |
$2.16M |
| 99215 |
Prolong outpt/office vis |
13,930 |
12,012 |
$1.82M |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
11,391 |
11,196 |
$1.52M |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
2,002 |
1,458 |
$1.49M |
| 80053 |
Comprehensive metabolic panel |
155,857 |
142,709 |
$1.33M |
| J1756 |
Injection, iron sucrose, 1 mg |
24,773 |
16,334 |
$1.25M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
256,335 |
211,958 |
$1.22M |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
4,076 |
973 |
$1.21M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,283 |
7,271 |
$1.07M |
| 82728 |
|
91,638 |
89,270 |
$1.06M |
| 88189 |
|
15,652 |
15,570 |
$923K |
| 88120 |
|
2,529 |
2,482 |
$877K |
| 88377 |
|
1,756 |
1,745 |
$780K |
| 87481 |
|
10,083 |
9,880 |
$691K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,695 |
2,693 |
$667K |
| 51729 |
|
1,846 |
1,842 |
$632K |
| 82607 |
|
52,631 |
51,972 |
$625K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,115 |
2,109 |
$597K |
| 77014 |
|
5,993 |
1,450 |
$567K |
| 99233 |
Prolong inpt eval add15 m |
6,281 |
3,671 |
$546K |
| 83550 |
|
82,291 |
80,165 |
$481K |
| 99205 |
Prolong outpt/office vis |
2,480 |
2,473 |
$467K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
17,143 |
16,936 |
$441K |
| 83540 |
|
88,421 |
86,183 |
$430K |
| 83615 |
|
92,041 |
85,737 |
$427K |
| 83735 |
|
87,803 |
81,497 |
$421K |
| 82746 |
|
34,465 |
34,015 |
$387K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,393 |
3,391 |
$373K |
| 84100 |
|
89,415 |
81,568 |
$351K |
| 72197 |
|
975 |
975 |
$323K |
| 88184 |
|
6,531 |
6,493 |
$323K |
| 84550 |
|
82,743 |
77,219 |
$318K |
| 87653 |
|
13,162 |
12,931 |
$304K |
| 76872 |
|
2,719 |
2,713 |
$303K |
| 88112 |
|
6,841 |
5,866 |
$299K |
| 87640 |
|
13,002 |
12,782 |
$296K |
| 87500 |
|
11,706 |
11,498 |
$270K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
10,340 |
10,176 |
$249K |
| 76775 |
|
4,456 |
4,433 |
$244K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,425 |
15,656 |
$243K |
| 74178 |
|
799 |
798 |
$233K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,862 |
1,860 |
$222K |
| 51784 |
|
3,840 |
3,831 |
$213K |
| A9595 |
Piflufolastat f-18, diagnostic, 1 millicurie |
52 |
52 |
$212K |
| 76770 |
|
2,164 |
2,162 |
$189K |
| 51728 |
|
1,015 |
1,014 |
$188K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,429 |
2,385 |
$182K |
| 76830 |
Ultrasound, transvaginal |
1,648 |
1,610 |
$174K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
524 |
520 |
$168K |
| 74183 |
|
458 |
458 |
$162K |
| 84403 |
|
7,519 |
7,454 |
$158K |
| 84153 |
|
11,201 |
11,126 |
$158K |
| 76857 |
|
4,297 |
4,221 |
$158K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,394 |
964 |
$151K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,403 |
1,402 |
$146K |
| 86334 |
|
7,656 |
7,579 |
$140K |
| 82378 |
|
8,304 |
7,776 |
$130K |
| 82784 |
|
7,337 |
7,235 |
$129K |
| 80050 |
General health panel |
4,293 |
4,229 |
$125K |
| 93976 |
|
896 |
892 |
$124K |
| 51741 |
|
7,975 |
7,596 |
$114K |
| 71250 |
|
714 |
714 |
$95K |
| 87641 |
|
4,321 |
4,216 |
$90K |
| 77427 |
|
572 |
312 |
$82K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,300 |
1,298 |
$81K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,399 |
8,242 |
$80K |
| 51798 |
|
7,598 |
7,487 |
$80K |
| 82670 |
|
3,340 |
3,327 |
$78K |
| 83521 |
|
3,514 |
3,477 |
$78K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
523 |
523 |
$77K |
| 80061 |
Lipid panel |
9,244 |
9,221 |
$74K |
| 84165 |
|
8,353 |
8,259 |
$69K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
602 |
602 |
$68K |
| 87529 |
|
1,103 |
1,096 |
$67K |
| 52000 |
|
323 |
322 |
$65K |
| 86300 |
|
3,767 |
3,561 |
$64K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,786 |
7,771 |
$64K |
| 81002 |
|
28,274 |
25,465 |
$62K |
| 85044 |
|
22,032 |
21,301 |
$56K |
| 96127 |
|
15,682 |
15,627 |
$56K |
| 76641 |
|
397 |
397 |
$52K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
474 |
473 |
$52K |
| 88360 |
|
642 |
607 |
$50K |
| 84146 |
|
3,120 |
3,107 |
$48K |
| 88344 |
|
291 |
287 |
$48K |
| 83001 |
|
3,116 |
3,109 |
$48K |
| 83002 |
|
3,098 |
3,091 |
$47K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,411 |
1,089 |
$46K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
399 |
399 |
$46K |
| 77049 |
|
137 |
136 |
$44K |
| 88342 |
|
556 |
542 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
832 |
805 |
$39K |
| 77336 |
|
587 |
293 |
$37K |
| 83010 |
|
3,021 |
3,000 |
$32K |
| 90834 |
Psychotherapy, 45 minutes with patient |
642 |
365 |
$31K |
| 76870 |
|
400 |
400 |
$31K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
282 |
255 |
$30K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
194 |
194 |
$29K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,088 |
1,082 |
$27K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,038 |
1,032 |
$27K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,076 |
1,070 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
17,113 |
14,095 |
$26K |
| 64566 |
|
288 |
127 |
$26K |
| 88341 |
|
318 |
313 |
$25K |
| 51792 |
|
93 |
93 |
$25K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
3,022 |
2,166 |
$25K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,999 |
1,897 |
$24K |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
137 |
137 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
502 |
459 |
$23K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,671 |
1,427 |
$21K |
| 96367 |
|
492 |
318 |
$21K |
| 84436 |
|
2,596 |
2,591 |
$14K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
8,129 |
7,429 |
$13K |
| 81025 |
|
2,676 |
2,586 |
$13K |
| 70491 |
|
66 |
66 |
$11K |
| 76536 |
|
110 |
110 |
$11K |
| 38222 |
|
76 |
76 |
$10K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
54 |
54 |
$10K |
| 77012 |
|
74 |
74 |
$8K |
| 82947 |
|
1,835 |
1,832 |
$8K |
| 51797 |
|
69 |
69 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
343 |
256 |
$7K |
| 99385 |
|
57 |
57 |
$7K |
| 85651 |
|
2,601 |
2,551 |
$7K |
| 80047 |
|
764 |
764 |
$7K |
| 88368 |
|
61 |
60 |
$6K |
| 87511 |
|
277 |
276 |
$6K |
| 97803 |
|
287 |
280 |
$6K |
| 97802 |
|
151 |
151 |
$6K |
| 93000 |
|
455 |
454 |
$6K |
| 99442 |
|
74 |
74 |
$6K |
| 90674 |
|
184 |
183 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
135 |
64 |
$5K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
236 |
186 |
$5K |
| 84479 |
|
1,284 |
1,282 |
$5K |
| 84439 |
|
627 |
620 |
$4K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
105 |
105 |
$4K |
| 82668 |
|
259 |
252 |
$4K |
| 80074 |
|
98 |
98 |
$4K |
| 84270 |
|
226 |
226 |
$4K |
| 99417 |
Prolong home eval add 15m |
135 |
111 |
$4K |
| 88108 |
|
79 |
74 |
$4K |
| 76642 |
|
39 |
38 |
$3K |
| 88369 |
|
12 |
12 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,700 |
2,684 |
$3K |
| 99490 |
Ccm add 20min |
379 |
377 |
$3K |
| 71271 |
|
27 |
27 |
$3K |
| 90682 |
|
42 |
42 |
$3K |
| 77300 |
|
27 |
27 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
317 |
316 |
$3K |
| 86301 |
|
205 |
194 |
$3K |
| 82232 |
|
249 |
244 |
$3K |
| 86304 |
|
185 |
181 |
$2K |
| 82248 |
|
570 |
567 |
$2K |
| A4649 |
Surgical supply; miscellaneous |
61 |
61 |
$2K |
| 77334 |
|
12 |
12 |
$2K |
| 90832 |
Psychotherapy, 30 minutes with patient |
27 |
13 |
$2K |
| 93970 |
|
13 |
13 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
14 |
13 |
$2K |
| 76818 |
|
16 |
14 |
$2K |
| 81000 |
|
472 |
464 |
$2K |
| 0012A |
|
48 |
48 |
$2K |
| 85610 |
|
470 |
447 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
49 |
24 |
$2K |
| 82565 |
|
334 |
334 |
$1K |
| 85014 |
|
757 |
757 |
$1K |
| 88374 |
|
26 |
26 |
$1K |
| 90661 |
|
39 |
39 |
$1K |
| 82785 |
|
117 |
114 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
19 |
12 |
$1K |
| 86141 |
|
136 |
136 |
$1K |
| 99497 |
|
15 |
15 |
$1K |
| 84520 |
|
308 |
308 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
932 |
595 |
$932.91 |
| 96417 |
|
13 |
12 |
$890.86 |
| 0011A |
|
28 |
28 |
$853.74 |
| 97162 |
|
12 |
12 |
$840.73 |
| 76377 |
|
16 |
16 |
$839.35 |
| 82627 |
|
42 |
42 |
$801.39 |
| 85730 |
|
143 |
142 |
$724.88 |
| 86800 |
|
63 |
63 |
$683.98 |
| J7050 |
Infusion, normal saline solution, 250 cc |
960 |
806 |
$628.14 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
91 |
91 |
$627.55 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
97 |
97 |
$622.46 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
19 |
19 |
$605.67 |
| 86431 |
|
121 |
121 |
$598.71 |
| 84154 |
|
27 |
27 |
$494.94 |
| 82043 |
|
113 |
113 |
$462.86 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
34 |
34 |
$430.33 |
| 86147 |
|
14 |
14 |
$412.37 |
| 86146 |
|
14 |
14 |
$412.37 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
866 |
865 |
$322.34 |
| 90756 |
|
19 |
18 |
$291.94 |
| 82550 |
|
54 |
54 |
$267.61 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$235.89 |
| 82247 |
|
185 |
185 |
$235.48 |
| 83690 |
|
47 |
47 |
$229.53 |
| 85060 |
|
13 |
13 |
$228.52 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
78 |
77 |
$168.39 |
| 80076 |
|
25 |
25 |
$156.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17 |
17 |
$114.41 |
| 86038 |
|
13 |
13 |
$97.17 |
| 84478 |
|
14 |
14 |
$70.48 |
| 82465 |
|
14 |
14 |
$59.51 |
| 85536 |
|
12 |
12 |
$44.67 |
| 82310 |
|
13 |
13 |
$28.13 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
18 |
12 |
$9.83 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
67 |
38 |
$1.70 |
| 0502F |
|
530 |
400 |
$0.00 |